Fortis Healthcare Limited
FORTIS · Hospitals · NSE
₹993
Current Market Price
Fair Value (DCF)
₹408
Discount to FV
-58.9%
Updated 2h ago
YieldIQ Score
40/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
52%
ROE
10.5%
Debt/Equity
0.35
WACC
9.5%
Market Cap
₹74,930 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
15.9%
Return on capital employed
EV / EBITDA
29.6×
Enterprise multiple
Debt / EBITDA
1.6×
Leverage vs earnings
Interest Coverage
5.3×
EBIT covers interest
Current Ratio
0.86×
Short-term liquidity
Asset Turnover
0.53×
Revenue per ₹ of assets
Revenue CAGR (3Y)
13.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹992.5
Bear case
Discount -306.7%
Base case
Discount -143.1%
Bull case
Discount -83.2%
Ratio Trends
FORTIS · last 9 annual periods
ROE
10.5%
ROCE
15.9%
Operating Margin
—
Debt / Equity
0.35×
PE
57.6×
EV / EBITDA
29.6×
Historical Financials
FORTIS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹5639 Cr | ₹6213 Cr | ₹6835 Cr | ₹7783 Cr | ₹9128 Cr | +12.8% |
| EBITDA | ₹1416 Cr | ₹1238 Cr | ₹1309 Cr | ₹1577 Cr | ₹2130 Cr | +10.7% |
| EBIT | ₹1110 Cr | ₹921 Cr | ₹979 Cr | — | — | -3.1% |
| PAT | ₹555 Cr | ₹589 Cr | ₹599 Cr | ₹774 Cr | ₹1042 Cr | +17.0% |
| EPS (diluted) | ₹7.35 | ₹7.80 | ₹7.93 | — | — | +1.9% |
| CFO | ₹865 Cr | ₹822 Cr | ₹1100 Cr | ₹1424 Cr | ₹1601 Cr | +16.6% |
| CapEx | ₹-215 Cr | ₹-447 Cr | ₹-942 Cr | ₹-847 Cr | ₹-945 Cr | — |
| FCF | ₹650 Cr | ₹375 Cr | ₹158 Cr | ₹577 Cr | ₹656 Cr | +0.2% |
| Total Assets | ₹11.9K Cr | ₹12.4K Cr | ₹13.3K Cr | ₹13.7K Cr | ₹16.0K Cr | +7.7% |
| Total Debt | ₹1255 Cr | ₹926 Cr | ₹1155 Cr | ₹2475 Cr | ₹3473 Cr | +29.0% |
| Shareholders' Equity | ₹6178 Cr | ₹7242 Cr | ₹7663 Cr | ₹8917 Cr | ₹9896 Cr | +12.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
FORTIS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 MAXHEALTH MAXHEALTH | — | — | Pending | 13.4% | — |
 APOLLOHOSP Apollo Hospitals Enterprise Limited | -54.6% | 40 | Above Fair Value | 20.5% | 54.9× |
 NH Narayana Hrudayalaya Ltd. | -57.0% | 35 | Above Fair Value | 17.8% | — |
 ASTERDM ASTERDM | — | — | Pending | 156.9% | — |
 MEDANTA Global Health Limited | -74.4% | 40 | Data Limited | 14.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
3 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹3.00/sh
Last payout
2025-07-25
₹1.00
Peak payout
₹1.00
Trailing yield
0.10%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Fortis Healthcare Limited (FORTIS.NS) trades at 992.50 vs a model fair value of 408.28, a gap of -58.9%. Piotroski F-score: 6/9. Moat lab...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of FORTIS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for FORTIS →
Compare
Head-to-head with peers
Compare FORTIS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse FORTISNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.